Advocacy intelligence hub — real-time data for patient organizations
Cordarone: FDA approved
For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Cordarone
Wyeth-Ayerst Laboratories
Cordarone
(Amiodarone HCl)Orphan drugWyeth-Ayerst Laboratories
Browse all Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant news →